Author: GlobeNewswire

CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop…

REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive…

Annual Product Sales for 2021 Increased 25% over 2020PORTLAND, Maine, Feb. 22, 2022 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”…

Conference Call and Webcast Scheduled for Monday, February 28, 2022, at 4:30 p.m. Eastern TimeREDWOOD CITY, Calif., Feb. 22, 2022…

Conference Call and Webcast Scheduled for Tuesday, March 1, 2022 at 4:30 p.m. EasternSAN DIEGO and GAINESVILLE, Ga., Feb. 22,…

MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing,…

EMERYVILLE, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the…

Received U.S. Food and Drug Administration (FDA) acceptance of the New Drug Application (NDA) for roflumilast cream for the treatment…

HAMPTON, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced it will host a conference call…